Orchid Pharma Limited — Others, 13-01-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Orchid Pharma has announced a board meeting to discuss compliance matters, supported by a confirmation certificate from their registrar and transfer agent for the third quarter of FY2024-25, concluding on December 31, 2024. This compliance underlines the company's adherence to operational regulations, which is crucial for sustaining governance standards. Investors may view this positively as it indicates stability and adherence to procedural requirements, promoting confidence in the company's management and operational integrity. However, ongoing compliance will be essential for maintaining investor sentiment and trust.